Business news

Active Psoriatic Arthritis Market Revenue Poised for Significant Growth During the Forecast Period of 2020-2027

The global Active Psoriatic Arthritis Market was estimated at USD 7.15 billion in 2019 and is anticipated to reach USD 13.64 billion by 2027, at a CAGR of 9.2%, according to the most recent Emergen Research report. Along with an increase in the senior population, emerging countries are seeing a significant increase in the occurrences of active psoriatic arthritis. Additionally, a low standard of living brought on by a difficult work-life balance that overstimulates the immune system Growing improvements in biosimilars and a strong pipeline of biological drugs is significantly expanding the number of safe and effective treatments for psoriatic arthritis. Patients who already have plaque psoriasis frequently encounter a high incidence of psoriatic arthritis. These circumstances have a direct impact on the expansion of the active psoriatic arthritis market.

Additionally, the rapid adoption of hectic lifestyles that overstimulate the immune system, the easy availability of highly effective biological treatments for psoriasis, and the rising number of alternative therapies for psoriatic arthritis that have been approved are all predicted to boost the market shortly. Along with this, the development of telehealth services and online pharmacy options for getting prescriptions and medications delivered at home is projected to grow the industry.

Get a Sample Copy

Further key findings from the report suggest

  • The biologics drug class category had the biggest market share, or around 39.8%, due to the high prevalence and applicability of biologics and biosimilar medicines in prospective treatments. Traditional biologics also can enhance the entire immune system.
  • The majority of biologic and biosimilar products are only offered with a prescription. According to the products projection, the prescription products category generated the most market revenue in 2019 with a market share of almost 47.5%.
  • Lockdowns disrupted logistics and transportation.
  • worldwide mining and manufacturing businesses were affected
  • took a toll on the economies of several nations
  • caused an abrupt and severe decline in economic activity

Emerging research has segmented the Active Psoriatic Arthritis Market based on product, drug class, route of administration, and region:

Product Outlook (Revenue in Million USD; 2017–2027)

  • Prescriptions
  • OTC
  • Other

Drug Class Outlook (Revenue in Million USD; 2017–2027)

  • Biologics
  • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
  • Non-Biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs)
  • Other

By Route of Administration (Revenue in Million USD; 2017–2027)

  • Injectable
  • Oral
  • Topical

Regional Outlook (Revenue: USD Billion; Volume: Million Tons; 2017-2027)

  • North America
    1. S.
    2. Canada
  • Europe
    1. the UK
    2. Germany
    3. France
    4. BENELUX
  • the Asia Pacific
    1. China
    2. Japan
    3. South Korea
    4. Rest of APAC
  • Latin America
    1. Brazil
    2. Rest of LATAM
  • MEA
    1. Saudi Arabia
    2. UAE
    3. Rest of MEA

To get leading market solutions, Visit the link

To Top

Pin It on Pinterest

Share This